AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 INHIBITORS AS MARKERS OF DISEASE-ACTIVITY OF TUBERCULOSIS
Authors: JUFFERMANS NP VERBON A VANDEVENTER SJH VANDEUTEKOM H SPEELMAN P VANDERPOLL T
Citation: Np. Juffermans et al., TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 INHIBITORS AS MARKERS OF DISEASE-ACTIVITY OF TUBERCULOSIS, American journal of respiratory and critical care medicine, 157(4), 1998, pp. 1328-1331
INFECTION DUE TO NOCARDIA-FARCINICA IN A WOMAN WITH CHRONIC GRANULOMATOUS-DISEASE
Authors: FIJEN CAP SCHRAMA J KUIJPER EJ BOIRON P GERRITSEN W SPEELMAN P
Citation: Cap. Fijen et al., INFECTION DUE TO NOCARDIA-FARCINICA IN A WOMAN WITH CHRONIC GRANULOMATOUS-DISEASE, Clinical infectious diseases, 26(1), 1998, pp. 222-224
HISTOPATHOLOGIC CHANGES OF THE EYELID SKIN FOLLOWING TRICHLOROACETIC-ACID CHEMICAL PEEL
Authors: DAILEY RA GRAY JF RUBIN MG HILDEBRAND PL SWANSON NA WOBIG JL WILSON DJ SPEELMAN P
Citation: Ra. Dailey et al., HISTOPATHOLOGIC CHANGES OF THE EYELID SKIN FOLLOWING TRICHLOROACETIC-ACID CHEMICAL PEEL, Ophthalmic plastic and reconstructive surgery, 14(1), 1998, pp. 9-12
ONCE-DAILY AMINOGLYCOSIDES - PRACTICAL GUIDELINES
Authors: PRINS JM SPEELMAN P
Citation: Jm. Prins et P. Speelman, ONCE-DAILY AMINOGLYCOSIDES - PRACTICAL GUIDELINES, Netherlands journal of medicine, 52(1), 1998, pp. 1-9
MYCOBACTERIUM-XENOPI IN HIV-INFECTED PATIENTS - AN EMERGING PATHOGEN
Authors: JUFFERMANS NP VERBON A DANNER SA KUIJPER EJ SPEELMAN P
Citation: Np. Juffermans et al., MYCOBACTERIUM-XENOPI IN HIV-INFECTED PATIENTS - AN EMERGING PATHOGEN, AIDS, 12(13), 1998, pp. 1661-1666
ERYTHROMYCIN INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 PRODUCTION INDUCED BY HEAT-KILLED STREPTOCOCCUS-PNEUMONIAE IN WHOLE-BLOOD
Authors: SCHULTZ MJ SPEELMAN P ZAAT S VANDEVENTER SJH VANDERPOLL T
Citation: Mj. Schultz et al., ERYTHROMYCIN INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 PRODUCTION INDUCED BY HEAT-KILLED STREPTOCOCCUS-PNEUMONIAE IN WHOLE-BLOOD, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1605-1609
LEVELS OF INHIBITORS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN URINE AND SERA OF PATIENTS WITH UROSEPSIS
Authors: OLSZYNA DP PRINS JM BUIS B VANDEVENTER SJH SPEELMAN P VANDERPOLL T
Citation: Dp. Olszyna et al., LEVELS OF INHIBITORS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN URINE AND SERA OF PATIENTS WITH UROSEPSIS, Infection and immunity, 66(8), 1998, pp. 3527-3534
ENDOTOXIN RELEASE AND CYTOKINE PRODUCTION IN ACUTE AND CHRONIC MENINGOCOCCEMIA
Authors: PRINS JM LAUW FN DERKX BHF SPEELMAN P KUIJPER EJ DANKERT J VANDEVENTER SJH
Citation: Jm. Prins et al., ENDOTOXIN RELEASE AND CYTOKINE PRODUCTION IN ACUTE AND CHRONIC MENINGOCOCCEMIA, Clinical and experimental immunology, 114(2), 1998, pp. 215-219
NO INCREASE IN ENDOTOXIN RELEASE DURING ANTIBIOTIC KILLING OF MENINGOCOCCI
Authors: PRINS JM SPEELMAN P KUIJPER EJ DANKERT J VANDEVENTER SJH
Citation: Jm. Prins et al., NO INCREASE IN ENDOTOXIN RELEASE DURING ANTIBIOTIC KILLING OF MENINGOCOCCI, Journal of antimicrobial chemotherapy, 39(1), 1997, pp. 13-18
CIRCULATING AND EX-VIVO PRODUCTION OF PYROGENIC CYTOKINES AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN 123 PATIENTS WITH FEVER OF UNKNOWN ORIGIN
Authors: DEKLEIJN EMHA DRENTH JPH PESMAN GJ VANDRUTEN H DEMACKER PNM VANDERMEER JWM DEKLEIJN EMHA VANDERMEER JWM DEMACKER P CORSTENS FHM MEINDERS AE PAUWELS EKJ VANDENBROUCKE JP VANEER M KREEFTENBERG HG PIERS DR SPEELMAN P VANROYEN EA CLAESSEN F TEULE GJJ DEMARIE S KRENNING EP SCHNEIDER M HOEPELMAN A VANRIJK PP VANDERGEEST S HEIDENDAL GAK
Citation: Emha. Dekleijn et al., CIRCULATING AND EX-VIVO PRODUCTION OF PYROGENIC CYTOKINES AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN 123 PATIENTS WITH FEVER OF UNKNOWN ORIGIN, The Journal of infectious diseases, 175(1), 1997, pp. 191-195
CIPROFLOXACIN MAINTENANCE THERAPY IN THE PREVENTION OF CHOLANGITIS INPATIENTS WITH A BILIARY ENDOPROSTHESIS IN-SITU
Authors: VANDENHAZEL SJ SPEELMAN P HUIBREGTSE K DANKERT J TYTGAT GNJ VANLEEUWEN DJ
Citation: Sj. Vandenhazel et al., CIPROFLOXACIN MAINTENANCE THERAPY IN THE PREVENTION OF CHOLANGITIS INPATIENTS WITH A BILIARY ENDOPROSTHESIS IN-SITU, Gut, 41, 1997, pp. 64-64
CIRCADIAN VARIATIONS IN SERUM LEVELS AND THE RENAL TOXICITY OF AMINOGLYCOSIDES IN PATIENTS
Authors: PRINS JM WEVERLING GJ VANKETEL RJ SPEELMAN P
Citation: Jm. Prins et al., CIRCADIAN VARIATIONS IN SERUM LEVELS AND THE RENAL TOXICITY OF AMINOGLYCOSIDES IN PATIENTS, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 106-111
ANTIBIOTIC-PROPHYLAXIS BEFORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY - RESPONSE
Authors: VANDENHAZEL SJ SPEELMAN P VANLEEUWEN DJ
Citation: Sj. Vandenhazel et al., ANTIBIOTIC-PROPHYLAXIS BEFORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY - RESPONSE, Annals of internal medicine, 126(12), 1997, pp. 1001-1002
A HISTOLOGICAL COMPARISON OF 50-PERCENT AND 70-PERCENT GLYCOLIC ACID PEELS USING SOLUTIONS WITH VARIOUS PHS
Authors: BECKER FF LANGFORD FPJ RUBIN MG SPEELMAN P
Citation: Ff. Becker et al., A HISTOLOGICAL COMPARISON OF 50-PERCENT AND 70-PERCENT GLYCOLIC ACID PEELS USING SOLUTIONS WITH VARIOUS PHS, Dermatologic surgery, 22(5), 1996, pp. 463-465
DOSAGE SCHEDULES OF AMINOGLYCOSIDES
Authors: PRINS JM SPEELMAN P
Citation: Jm. Prins et P. Speelman, DOSAGE SCHEDULES OF AMINOGLYCOSIDES, Current opinion in infectious diseases, 9(6), 1996, pp. 398-402
KNOWN BACTERIAL VIRULENCE FACTORS DO NOT EXPLAIN THE VARIATION IN URINARY CYTOKINE LEVELS IN PATIENTS WITH UROSEPSIS
Authors: PRINS JM SCHULTSZ C SPEELMAN P VANDEVENTER SJH
Citation: Jm. Prins et al., KNOWN BACTERIAL VIRULENCE FACTORS DO NOT EXPLAIN THE VARIATION IN URINARY CYTOKINE LEVELS IN PATIENTS WITH UROSEPSIS, FEMS immunology and medical microbiology, 16(3-4), 1996, pp. 283-289
VALIDATION AND NEPHROTOXICITY OF A SIMPLIFIED ONCE-DAILY AMINOGLYCOSIDE DOSING SCHEDULE AND GUIDELINES FOR MONITORING THERAPY
Authors: PRINS JM WEVERLING GJ DEBLOK K VANKETEL RJ SPEELMAN P
Citation: Jm. Prins et al., VALIDATION AND NEPHROTOXICITY OF A SIMPLIFIED ONCE-DAILY AMINOGLYCOSIDE DOSING SCHEDULE AND GUIDELINES FOR MONITORING THERAPY, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2494-2499
BILIARY-EXCRETION OF CIPROFLOXACIN AND PIPERACILLIN IN THE OBSTRUCTEDBILIARY-TRACT
Authors: VANDENHAZEL SJ DEVRIES XH SPEELMAN P DANKERT J TYTGAT GNJ HUIBREGTSE K VANLEEUWEN DJ
Citation: Sj. Vandenhazel et al., BILIARY-EXCRETION OF CIPROFLOXACIN AND PIPERACILLIN IN THE OBSTRUCTEDBILIARY-TRACT, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2658-2660
THE ACCURACY OF THE PRE-ERCP DIAGNOSIS IN PATIENTS WITH SUSPECTED BILE-DUCT STONES OR DISTAL BILE-DUCT
Authors: VANDENHAZEL SJ DEVRIES XH SPEELMAN P HUIBREGTSE K TYTGAT GNJ VANLEEUWEN DJ
Citation: Sj. Vandenhazel et al., THE ACCURACY OF THE PRE-ERCP DIAGNOSIS IN PATIENTS WITH SUSPECTED BILE-DUCT STONES OR DISTAL BILE-DUCT, Gastrointestinal endoscopy, 43(4), 1996, pp. 442-442
PIPERACILLIN TO PREVENT CHOLANGITIS AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY - A RANDOMIZED, CONTROLLED TRIAL
Authors: VANDENHAZEL SJ SPEELMAN P DANKERT J HUIBREGTSE K TYTGAT GNJ VANLEEUWEN DJ
Citation: Sj. Vandenhazel et al., PIPERACILLIN TO PREVENT CHOLANGITIS AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 125(6), 1996, pp. 442-447
EASIER MONITORING OF AMINOGLYCOSIDE THERAPY WITH ONCE-DAILY DOSING SCHEDULES
Authors: PRINS JM KOOPMANS RP BULLER HR KUIJPER EJ SPEELMAN P
Citation: Jm. Prins et al., EASIER MONITORING OF AMINOGLYCOSIDE THERAPY WITH ONCE-DAILY DOSING SCHEDULES, European journal of clinical microbiology & infectious diseases, 14(6), 1995, pp. 531-535
OTOTOXICITY AND NEPHROTOXICITY OF GENTAMICIN VS NETILMICIN IN PATIENTS WITH SERIOUS INFECTIONS - A RANDOMIZED CLINICAL-TRIAL
Authors: TANGE RA DRESCHLER WA PRINS JM BULLER HR KUIJPER EJ SPEELMAN P
Citation: Ra. Tange et al., OTOTOXICITY AND NEPHROTOXICITY OF GENTAMICIN VS NETILMICIN IN PATIENTS WITH SERIOUS INFECTIONS - A RANDOMIZED CLINICAL-TRIAL, Clinical otolaryngology and allied sciences, 20(2), 1995, pp. 118-123
ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE IN PATIENTS WITH GRAM-NEGATIVE UROSEPSIS - A DOUBLE-BLIND-STUDY COMPARING IMIPENEM AND CEFTAZIDIME
Authors: PRINS JM VANAGTMAEL MA KUIJPER EJ VANDEVENTER SJH SPEELMAN P
Citation: Jm. Prins et al., ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE IN PATIENTS WITH GRAM-NEGATIVE UROSEPSIS - A DOUBLE-BLIND-STUDY COMPARING IMIPENEM AND CEFTAZIDIME, The Journal of infectious diseases, 172(3), 1995, pp. 886-891
RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 DURING ANTIBIOTIC KILLING OF ESCHERICHIA-COLI IN WHOLE-BLOOD - INFLUENCE OF ANTIBIOTIC CLASS, ANTIBIOTIC CONCENTRATION, AND PRESENCE OF SEPTIC SERUM
Authors: PRINS JM KUIJPER EJ MEVISSEN MLCM SPEELMAN P VANDEVENTER SJH
Citation: Jm. Prins et al., RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 DURING ANTIBIOTIC KILLING OF ESCHERICHIA-COLI IN WHOLE-BLOOD - INFLUENCE OF ANTIBIOTIC CLASS, ANTIBIOTIC CONCENTRATION, AND PRESENCE OF SEPTIC SERUM, Infection and immunity, 63(6), 1995, pp. 2236-2242
ANTIBIOTIC-PROPHYLAXIS WITH PIPERACILLIN (PIP) DOES NOT PREVENT ERCP-INDUCED CHOLANGITIS
Authors: VANDENHAZEL SJ SPEELMAN P TYTGAT GNJ DANKERT J VANLEEUWEN DJ
Citation: Sj. Vandenhazel et al., ANTIBIOTIC-PROPHYLAXIS WITH PIPERACILLIN (PIP) DOES NOT PREVENT ERCP-INDUCED CHOLANGITIS, Gastrointestinal endoscopy, 41(4), 1995, pp. 332-332
Risultati: 1-25 | 26-35